PL372210A1 - Połączenia alfa-2-delta ligandu z selektywnym inhibitorem cyklooksygenazy-2 - Google Patents
Połączenia alfa-2-delta ligandu z selektywnym inhibitorem cyklooksygenazy-2Info
- Publication number
- PL372210A1 PL372210A1 PL03372210A PL37221003A PL372210A1 PL 372210 A1 PL372210 A1 PL 372210A1 PL 03372210 A PL03372210 A PL 03372210A PL 37221003 A PL37221003 A PL 37221003A PL 372210 A1 PL372210 A1 PL 372210A1
- Authority
- PL
- Poland
- Prior art keywords
- cyclooxygenase
- alpha
- combinations
- selective inhibitor
- delta ligand
- Prior art date
Links
- 102000010907 Cyclooxygenase 2 Human genes 0.000 title 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 title 1
- 229940124639 Selective inhibitor Drugs 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35929502P | 2002-02-22 | 2002-02-22 | |
| US40436502P | 2002-08-19 | 2002-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL372210A1 true PL372210A1 (pl) | 2005-07-11 |
Family
ID=27760521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03372210A PL372210A1 (pl) | 2002-02-22 | 2003-02-12 | Połączenia alfa-2-delta ligandu z selektywnym inhibitorem cyklooksygenazy-2 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20030199567A1 (pl) |
| EP (1) | EP1480639A1 (pl) |
| JP (1) | JP2005523281A (pl) |
| KR (1) | KR20040085216A (pl) |
| CN (1) | CN1635887A (pl) |
| AR (1) | AR038531A1 (pl) |
| AU (1) | AU2003246864A1 (pl) |
| BR (1) | BR0307906A (pl) |
| CA (1) | CA2476438A1 (pl) |
| CO (1) | CO5611109A2 (pl) |
| HN (1) | HN2003000071A (pl) |
| IL (1) | IL162932A0 (pl) |
| MX (1) | MXPA04008175A (pl) |
| NO (1) | NO20043947L (pl) |
| PA (1) | PA8567201A1 (pl) |
| PE (1) | PE20031052A1 (pl) |
| PL (1) | PL372210A1 (pl) |
| RU (1) | RU2286151C2 (pl) |
| TW (1) | TW200303214A (pl) |
| UY (1) | UY27675A1 (pl) |
| WO (1) | WO2003070237A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006511606A (ja) * | 2002-12-13 | 2006-04-06 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 下部尿路症状を治療するα−２−δリガンド |
| WO2004084880A1 (en) * | 2003-03-21 | 2004-10-07 | Dynogen Pharmaceuticals, Inc. | METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS |
| WO2004084881A1 (en) * | 2003-03-21 | 2004-10-07 | Dynogen Pharmaceuticals, Inc. | METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS |
| ES2275229T3 (es) * | 2003-03-21 | 2007-06-01 | Dynogen Pharmaceuticals, Inc. | Metodos para el tratamiento de desordenes del tracto urinario iferior utilizando antimuscarinos y moduladores de la subunidad alfa-2-delta del canal de calcio. |
| US7169812B2 (en) | 2003-07-01 | 2007-01-30 | Medtronic, Inc. | Process for producing injectable gabapentin compositions |
| EP1663398B1 (en) * | 2003-09-12 | 2009-11-25 | Pfizer Limited | Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors |
| GB0322140D0 (en) * | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
| EP1682149B1 (en) * | 2003-10-23 | 2009-12-02 | Medtronic, Inc. | Injectable gabapentin compositions |
| WO2007115821A2 (en) * | 2006-04-11 | 2007-10-18 | Novartis Ag | Organic compounds |
| CA2673375A1 (en) * | 2006-12-22 | 2008-07-03 | Novartis Ag | 1-aminomethyl-l-phenyl-cyclohexane derivatives as ddp-iv inhibitors |
| MX2010012080A (es) * | 2008-05-05 | 2011-04-11 | Univ Winthrop Hospital | Metodo para mejorar el perfil de riesgo cardiovascular de los inhibidores de cox. |
| KR101730924B1 (ko) * | 2008-09-05 | 2017-04-27 | 그뤼넨탈 게엠베하 | 3-（3-디메틸아미노-1-에틸-2-메틸-프로필）-페놀과 항간질제의 약제학적 병용물 |
| KR102631399B1 (ko) | 2018-03-30 | 2024-02-01 | 씨지인바이츠 주식회사 | 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물 |
| CN116782897A (zh) * | 2020-10-28 | 2023-09-19 | 特默罗制药股份有限公司 | 水不溶性的cox-2抑制剂的水性制剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234929A (en) * | 1992-07-20 | 1993-08-10 | William Chelen | Method of treating motion sickness with anticonvulsants and antitussive agents |
| US5321012A (en) * | 1993-01-28 | 1994-06-14 | Virginia Commonwealth University Medical College | Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance |
| US5420270A (en) * | 1993-10-07 | 1995-05-30 | G. D. Searle & Co. | Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US5352638A (en) * | 1994-02-22 | 1994-10-04 | Corning Incorporated | Nickel aluminosilicate glass-ceramics |
| CZ291757B6 (cs) * | 1994-07-27 | 2003-05-14 | Warner-Lambert Company | Léčivo pro léčení úzkosti a panického strachu |
| US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| AU8668598A (en) * | 1997-08-20 | 1999-03-08 | University Of Oklahoma, The | Gaba analogs to prevent and treat gastrointestinal damage |
| HU226165B1 (en) * | 1997-09-08 | 2008-05-28 | Warner Lambert Co | Analgesic compositions comprising anti-epileptic compounds and non-steroid anti-inflammatory dr4gs |
| KR20010033153A (ko) * | 1997-12-16 | 2001-04-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 4(3)-치환-4(3)-아미노메틸-(티오)피란 또는 -피페리딘유도체(=가바펜틴 동족체), 그의 제법 및 신경 질환 치료용도 |
| JP2002538221A (ja) * | 1999-03-10 | 2002-11-12 | ワーナー−ランバート・カンパニー | 抗てんかん作用を有する化合物を包含する鎮痛組成物およびその使用方法 |
| HN2000000224A (es) * | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
| GB9927844D0 (en) * | 1999-11-26 | 2000-01-26 | Glaxo Group Ltd | Chemical compounds |
| HRP20010582A2 (en) * | 1999-12-08 | 2002-08-31 | Pharmacia Corp | Valdecoxib compositions |
-
2003
- 2003-02-12 PL PL03372210A patent/PL372210A1/pl not_active Application Discontinuation
- 2003-02-12 MX MXPA04008175A patent/MXPA04008175A/es unknown
- 2003-02-12 CA CA002476438A patent/CA2476438A1/en not_active Abandoned
- 2003-02-12 CN CNA038043564A patent/CN1635887A/zh active Pending
- 2003-02-12 JP JP2003569193A patent/JP2005523281A/ja not_active Abandoned
- 2003-02-12 BR BR0307906-6A patent/BR0307906A/pt not_active IP Right Cessation
- 2003-02-12 KR KR10-2004-7013032A patent/KR20040085216A/ko not_active Ceased
- 2003-02-12 AU AU2003246864A patent/AU2003246864A1/en not_active Abandoned
- 2003-02-12 EP EP03742460A patent/EP1480639A1/en not_active Withdrawn
- 2003-02-12 WO PCT/IB2003/000534 patent/WO2003070237A1/en not_active Ceased
- 2003-02-12 IL IL16293203A patent/IL162932A0/xx unknown
- 2003-02-12 RU RU2004125609/15A patent/RU2286151C2/ru not_active IP Right Cessation
- 2003-02-14 US US10/366,798 patent/US20030199567A1/en not_active Abandoned
- 2003-02-17 PE PE2003000166A patent/PE20031052A1/es not_active Application Discontinuation
- 2003-02-19 UY UY27675A patent/UY27675A1/es not_active Application Discontinuation
- 2003-02-20 AR ARP030100547A patent/AR038531A1/es unknown
- 2003-02-21 TW TW092103596A patent/TW200303214A/zh unknown
- 2003-02-21 HN HN2003000071A patent/HN2003000071A/es unknown
- 2003-02-21 PA PA20038567201A patent/PA8567201A1/es unknown
-
2004
- 2004-08-13 CO CO04079024A patent/CO5611109A2/es not_active Application Discontinuation
- 2004-09-21 NO NO20043947A patent/NO20043947L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1480639A1 (en) | 2004-12-01 |
| CO5611109A2 (es) | 2006-02-28 |
| MXPA04008175A (es) | 2004-11-26 |
| PE20031052A1 (es) | 2003-12-24 |
| WO2003070237A1 (en) | 2003-08-28 |
| HN2003000071A (es) | 2003-11-24 |
| PA8567201A1 (es) | 2003-11-12 |
| BR0307906A (pt) | 2004-12-21 |
| CN1635887A (zh) | 2005-07-06 |
| TW200303214A (en) | 2003-09-01 |
| KR20040085216A (ko) | 2004-10-07 |
| JP2005523281A (ja) | 2005-08-04 |
| IL162932A0 (en) | 2005-11-20 |
| NO20043947L (no) | 2004-09-21 |
| RU2286151C2 (ru) | 2006-10-27 |
| US20030199567A1 (en) | 2003-10-23 |
| UY27675A1 (es) | 2003-09-30 |
| CA2476438A1 (en) | 2003-08-28 |
| AU2003246864A1 (en) | 2003-09-09 |
| AR038531A1 (es) | 2005-01-19 |
| RU2004125609A (ru) | 2006-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL162932A0 (en) | Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 | |
| HUP0600294A2 (en) | Skin-permeable selective cyclooxygenase-2 inhibitor composition | |
| GB0618535D0 (en) | A solution of metal-polymer chelate(s) and applications thereof | |
| AU2003278039A1 (en) | Nitric oxide releasing selective cyclooxygenase-2 inhibitors | |
| AU2003238042A1 (en) | Cyclooxygenase-2 inhibitors | |
| PL374279A1 (pl) | Nitrooksypochodne inhibitorów cyklooksygenazy-2 | |
| AU2003233426A8 (en) | Corrosion inhibitor | |
| GB0307401D0 (en) | A fastener | |
| GB0212003D0 (en) | Seabed anchor | |
| HUP0600235A3 (en) | Combinations comprising a selective cyclooxygenase-2 inhibitor | |
| AU2003287733A1 (en) | Selective cyclooxygenase-2 inhibitor patch | |
| PL373523A1 (pl) | Indol-2-ony jako selektywne inhibitory cyklooksygenazy-2 | |
| PL1680635T3 (pl) | Lodówka | |
| ZA200607990B (en) | A solution of metal-polymer chelate(s) and applications thereof | |
| AU2003303625A8 (en) | Combination of reboxetine and a cyclooxygenase-2 inhibitor | |
| AU2002367951A8 (en) | The use of the inhibitor transmitter of gamma-aminobutyric acid (gaba) in the manufacture of analgesic | |
| IL176473A0 (en) | Neutrophilia inhibitor | |
| GB0219365D0 (en) | A vice | |
| PL113009U1 (en) | Maritime launcher | |
| GB0226207D0 (en) | Yum Yum | |
| GB0305525D0 (en) | Inhibitor based sequencing technology | |
| AU2945P (en) | Exciting Love Anthurium andraeanum | |
| GB0221244D0 (en) | Quick shift trigger | |
| GB2434614B (en) | A fastener | |
| AU154700S (en) | A lowboy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |